Biorestorative Therapies, Inc. (OTCBB: BRTX) develops products and medical procedures using cell and tissue protocols, primarily involving adult stem cells. The company’s portfolio includes brtxDISC™, an investigational non-surgical treatment for protruding, bulging and herniated lumbar discs; ThermoStem®, under development for metabolic disorders including diabetes and obesity; and brtx-C Cosmetic, which has been demonstrated in in vitro skin studies to increase the production of collagen and fibronectin. The company also offers plant stem cell-based facial creams and beauty products under the Stem Pearls® brand. For more information, visit the company’s website at www.biorestorative.com